Germany Plans EU Strategy to Challenge U.S. Tech and Pharmaceutical Firms

Germany is reportedly preparing a strategy for the European Union to exert pressure on U.S. technology companies, pharmaceutical suppliers, and manufacturers amid ongoing tensions with U.S. President Donald Trump. Bloomberg posted on X, citing sources familiar with the matter, that the plan aims to address disputes with the U.S. administration by targeting key sectors. The initiative reflects Germany's growing concerns over trade imbalances and regulatory challenges posed by American firms. The move comes as the EU seeks to strengthen its position in negotiations and protect its economic interests. Further details on the strategy are yet to be disclosed, but it underscores the EU's intent to assert its influence in global trade discussions.